CDKN2A and neoplasm: The authors concluded that transformation to a premalignant state is driven by increasing CDKN2A/B deficiency, and the tumor with the homozygous deletion defined a category now called “atypical neurofibromatous neoplasms of uncertain biologic potential” (ANNUBP).